Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016
Dominick Bossé(Dana-Farber Cancer Institute), Tim Asmis(Queen's University), Rakesh Goel(Ottawa Hospital), Rachel Goodwin(University of Ottawa), Prosanto Chaudhury(McGill University Health Centre), James D. Brierley(University of Toronto), A. Mahmud(Queen's University), Neil Kopek(McGill University Health Centre), Sean P. Cleary(University Health Network), M. Thirwell(McGill University Health Centre), Ali Al-Fakeeh(McGill University Health Centre), Laura A. Dawson(Princess Margaret Cancer Centre), Brian Colwell, É. Ferland(McGill University Health Centre), Stephanie Snow(Dalhousie University), Ibrahim M Alruzug(McGill University Health Centre), Tat Fong Ng(Queen's University), Евдокия Цветкова(Queen's University), Guillaume Martel(Ottawa Hospital), Samantha Gray(Queen Elizabeth II Health Sciences Centre), Lucas Sidéris(McGill University Health Centre), Polymnia Galiatsatos(McGill University Health Centre), C. Cripps(Canadian Partnership Against Cancer), Tina Hsu(University of Ottawa), Brian J. Ward(McGill University Health Centre), Sandrine Girard(Hospices Civils de Lyon), Liliane Robillard(University of California, San Francisco), M. Dorreen(Saint John Regional Hospital), Chaudhary E. Ahmad(Dr. H. Bliss Murphy Cancer Centre), Melanie Seal(Dr. H. Bliss Murphy Cancer Centre), Benoît Samson(Hôpital Charles-Le Moyne), F Halwani(Queen's University), J. Siddiqui(Dr. H. Bliss Murphy Cancer Centre), Michael M. Vickers(Ottawa Hospital), James Biagi(Université Paris Cité)
Cited by 7
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.9k
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
|The Lancet|2019|1.9k
The International Position on Laparoscopic Liver Surgery
|Annals of Surgery|2009|1.5k
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
|Journal of Clinical Oncology|2020|1.3k
Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma
|Journal of Clinical Oncology|2013|841